Home > Insider Trading > Filing (0001086377-13-000002)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1168220	Uluru Inc.	ULUR	Pharmaceutical Preparations (2834)	412118656

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1372353	K Terrance Wallberg	C/O Uluru Inc. 4452 Beltway Drive Addison TX 75001	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-03-14	100,000	$0.40	124,257	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant	Acquisiton	2013-03-14	60,000	$0.60	60,000	$0.60

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
60,000	2013-09-10	2018-03-14	No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Employee Stock Option (Right to Buy)	$14.25		2016-12-06	13,334	13,334	Direct
Common Stock	Employee Stock Option (Right to Buy)	$34.65		2018-02-12	5,334	5,334	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2016-12-06	13,334	13,334	Direct
2018-02-12	5,334	5,334	Direct

Footnotes

On March 14, 2013, Mr. Wallberg purchased from the Company 100,000 shares of common stock at a price of $0.40 per share. The purchase will take place at the following four closings over the next twelve months: (i) 20,000 shares of common stock will be purchased at a price of $8,000 at the initial closing on March 14, 2013, (ii) 25,000 shares of common stock will be purchased at a price of $10,000 on July 14, 2013, (iii) 30,000 shares of common stock will be purchased at a price of $12,000 on November 14, 2013, and (iv) 25,000 shares of common stock will be purchased at a price of $10,000 on March 14, 2014. In connection with his purchase of the Company's common stock, Mr. Wallberg was also issued a warrant to acquire up to 60,000 shares of the Company's common stock at a fixed exercise price of $0.60 per share. The warrant will become exercisable on September 10, 2013 subject to payment of the sums described above and has an expiration date of March 14, 2018.
These employee stock options became fully vested on December 6, 2010.
These employee stock options became fully vested on February 12, 2012.